Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

Lorus Therapeutics | Headlines

  • Vol:
  • Last Trade:
Search found 15 documents NextNext
1: Lorus Therapeutics Reports First Quarter Results for Fiscal Year 2010
Marketwire, October 6, 2009 08:15 AM

2: Lorus Announces Publication Supporting Novel Mode of Anticancer Therapy for LOR-253 Class of Compounds
Marketwire, September 21, 2009 08:01 AM

3: Lorus Therapeutics Announces Allowance of Patent for LOR-2040 in Japan
Marketwire, August 5, 2009 10:00 AM

4: Lorus Therapeutics Reports Results for Fiscal Year 2009
Marketwire, July 27, 2009 11:00 AM

5: Lorus Announces Publication of a Novel Analytical Method Confirming the Pharmacological Action of Its Anticancer Drug LOR-2040
Marketwire, June 29, 2009 07:01 AM

6: Lorus Therapeutics Announces Settlement of Secured Convertible Debentures
Marketwire, June 22, 2009 09:09 PM

7: Lorus Therapeutics Announces a Cooperative Research and Development Agreement With the U.S. National Cancer Institute
Marketwire, May 19, 2009 08:20 AM

8: Lorus Therapeutics Announces Presentation of New Supportive Data for LOR-2040 in Acute Myeloid Leukemia
Marketwire, April 22, 2009 08:16 AM

9: Lorus Therapeutics Presents New Findings for First-in-class Anticancer Drug Candidate LOR-253
Marketwire, April 20, 2009 08:15 AM

10: Lorus Announces Report of Evidence of Clinical Activity in Clinical Trial of LOR-2040 Combined With Capecitabine and Oxaliplatin in the Treatment of Advanced Metastatic Solid Tumors
Marketwire, April 15, 2009 08:15 AM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top